Adam Koppel serves as Executive at PTC THERAPEUTICS, INC., where they oversee executive responsibilities. Since joining the company, Adam Koppel has executed 39 insider transactions totaling $437.7M, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 1, 2024 involved selling 3,282 shares valued at $0.
Adam Koppel currently holds 10,461 shares of PTC THERAPEUTICS, INC. (PTCT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Adam Koppel has been a net buyer of PTCT stock. They have purchased $273.4M and sold $164.3M worth of shares.
Adam Koppel's most recent insider trade was on Aug 1, 2024, when they sold 3,282 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 1, 2024 | CERE | $0 | Disposition | 65,679,781 | $N/A | Discretionary |
| Jun 5, 2024 | CERE | $0 | Award | 10,461 | $N/A | Discretionary |
| Jan 11, 2024 | SLDB | $5.0M | Award | 904,160 | $5.53 | Discretionary |
| Oct 16, 2023 | CERE | $125.0M | Purchase | 5,480,052 | $22.81 | Discretionary |
| Jun 7, 2023 | CERE | $0 | Other | 432,627 | $N/A | Discretionary |
| Jun 7, 2023 | CERE | $0 | Award | 3,282 | $N/A | Discretionary |
| Dec 28, 2021 | DRNA | $127.5K | Tender | 3,333 | $38.25 | Discretionary |
| Dec 28, 2021 | DRNA | $117.8M | Tender | 3,080,237 | $38.25 | Discretionary |
| Jun 3, 2021 | DRNA | $0 | Option Exercise | 3,333 | $N/A | Discretionary |
| Mar 23, 2021 | SLDB | $5.0M | Award | 869,565 | $5.75 | Discretionary |
| Mar 9, 2021 | SWTX | $103.7M | Sale | 1,450,000 | $71.50 | Discretionary |
| Dec 10, 2020 | SLDB | $11.8M | Award | 3,189,189 | $3.70 | Discretionary |
| Dec 10, 2020 | DRNA | $23.4M | Sale | 1,000,000 | $23.40 | Discretionary |
| Nov 9, 2020 | CERE | $3.4M | Purchase | 332,293 | $10.30 | Discretionary |
| Oct 27, 2020 | CERE | $100.0M | Purchase | 10,000,000 | $10.00 | Discretionary |
| Oct 27, 2020 | CERE | $0 | Other | 49,961,943 | $N/A | Discretionary |
| Oct 26, 2020 | BLSA | $4.9M | Award | 487,500 | $10.00 | Discretionary |
| Feb 4, 2020 | ARQT | $0 | Conversion | 2,825,602 | $N/A | Discretionary |
| Feb 4, 2020 | ARQT | $5.0M | Purchase | 294,117 | $17.00 | Discretionary |
| Feb 4, 2020 | ARQT | $0 | Conversion | 859,573 | $N/A | Discretionary |
| Jan 14, 2020 | APTX | $10.0M | Purchase | 3,333,333 | $3.00 | Discretionary |
| Dec 4, 2019 | DRNA | $37.0M | Sale | 1,500,000 | $24.68 | Discretionary |
| Jul 30, 2019 | SLDB | $8.7M | Award | 1,881,720 | $4.65 | Discretionary |
| Jun 25, 2018 | APTX | $0 | Conversion | 1,825,092 | $N/A | Discretionary |
| Jun 25, 2018 | APTX | $6.4M | Purchase | 400,000 | $16.00 | Discretionary |
| Jan 30, 2018 | SLDB | $4.8M | Purchase | 300,000 | $16.00 | Discretionary |
| Jan 25, 2018 | SLDB | $0 | Option Exercise | 1,689,444 | $N/A | Discretionary |
| Jun 6, 2016 | BIIB | $160.9K | Sale | 555 | $290.00 | Discretionary |